2021
DOI: 10.1161/circresaha.120.318277
|View full text |Cite
|
Sign up to set email alerts
|

Loss of Endogenously Cycling Adult Cardiomyocytes Worsens Myocardial Function

Abstract: Rationale: Endogenously cycling adult cardiomyocytes (CMs) increase after myocardial infarction (MI) but remain scare, and are generally thought not to contribute to myocardial function. However, this broadly held assumption has not been tested, mainly because of the lack of transgenic reporters that restrict Cre expression to adult CMs that reenter the cell cycle. Objective: We created and validated a new transgenic mouse, αMHC-MerDreMer-Ki67p-RoxedCre::Rox-Lox-tdTomato-eGFP (denoted αDKRC) that restricts Cre… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(26 citation statements)
references
References 76 publications
0
22
0
Order By: Relevance
“…Importantly, the MADM mouse technology has limitations in addition to the efficiency of labeling recombination events that can potentially underestimate the quantifica- αMHC-MerDreMer-Ki67p-RoxedCre (αDKRC) mice. Advanced non-Cre DNA recombinases, such as Dre [77][78][79], VCre [80,81], SCre [80,81], and FLP [82,83] with DNA recognition sites other than LoxP, have unlocked the possibilities to engineer more sophisticated transgenic mice and interrogate temporal and lineage-specific cell biology [6,78,84]. Combining inducible non-Cre recombinases (MerDreMer) with modified Cre recombinases (RoxedCre) facilitates existing LoxP transgenics to answer previously unsolved questions in biology and disease.…”
Section: Transgenic Reporter Mice Of Previously Cycled Cellsmentioning
confidence: 99%
See 3 more Smart Citations
“…Importantly, the MADM mouse technology has limitations in addition to the efficiency of labeling recombination events that can potentially underestimate the quantifica- αMHC-MerDreMer-Ki67p-RoxedCre (αDKRC) mice. Advanced non-Cre DNA recombinases, such as Dre [77][78][79], VCre [80,81], SCre [80,81], and FLP [82,83] with DNA recognition sites other than LoxP, have unlocked the possibilities to engineer more sophisticated transgenic mice and interrogate temporal and lineage-specific cell biology [6,78,84]. Combining inducible non-Cre recombinases (MerDreMer) with modified Cre recombinases (RoxedCre) facilitates existing LoxP transgenics to answer previously unsolved questions in biology and disease.…”
Section: Transgenic Reporter Mice Of Previously Cycled Cellsmentioning
confidence: 99%
“…In mice, the majority of cardiomyocytes are determined within the first week of postnatal life, followed by two waves of DNA synthesis leading to binucleation and increased ploidy, a measure of genome size [ 4 ]. A small fraction of cardiomyocytes re-enter the cell cycle in response to injury [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]; however, cytokinesis is incomplete after cardiomyocytes re-enter the cell cycle, leading to further polyploidization and limited generation of new cardiomyocytes [ 14 ]. Human cardiomyocyte turnover is ~0.04% in the first year of life and ~0.01% per year in adulthood based on nuclear bomb test-derived radioisotope decay estimates [ 4 , 5 , 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, in vivo models [ 126 , 127 ] and hiPS-derived cardiomyocytes [ 128 ] have been generated to study cell cycle progression in the heart using FUCCI indicators. Interestingly, a recent study generated a Ki67-based lineage and traced mice to track the cell cycle activation in cardiomyocytes [ 129 ]. Finally, a recent preprint described the generation of an Aurora kinase B-based reporter to be used in identification of cardiomyocyte cell cycle activation in vitro and in vivo [ 36 ].…”
Section: Recent Genetic Tools To Track Cardiomyocyte Cell Cyclingmentioning
confidence: 99%